A review on Revolutionizing Healthcare in injectable and transdermal Drug Delivery system.

Abstract

Recent breakthroughs in drug delivery systems have transformed the landscape of healthcare, offering unprecedented precision, personalization, and efficiency in the administration of medications. Nanotechnology, exemplified by nanoparticles and liposomes, has revolutionized drug delivery, improved drug stability and targeting specific cells or tissues. This development has revolutionized cancer therapy, significantly reduced systemic toxicity while enhanced treatment efficacy. Antibody-drug conjugates (ADCs) have emerged as a powerful tool in targeted therapies. These ingenious compounds combine monoclonal antibodies with potent cytotoxic drugs, resulting in the selective delivery of therapeutics to cancer cells. ADCs are at the forefront of treatment for various cancers, particularly HER2-positive breast cancer. Smart drug delivery systems are ushering in a new era of patient-centric care, integrating sensors, control systems, and actuators to monitor and adjust drug administration in real time. Devices like insulin pumps, inhalers, and implantable systems empower patients to exert greater control over their treatments, thereby improving compliance and overall outcomes.